B16F10-OVAPanc02 tumorsSyntiGenKoch InstituteSyntiGen-primedDFCIBridge grant
…was tested in immunocompetent C57BL/6 mice bearing subcutaneous B16F10-OVA or Panc02 tumors, treated intravenously with engineered bacteri…
1articles mentioning diseases
1disease mentions
1distinct diseases extracted
0%of mentions human-reviewed
Active filtersEntity: B16F10-OVA ×
B16F10-OVA
This disease is selected. Its supporting articles are shown below.